about
Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?Attenuation by incretins of thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.Diabetes Drug Effects on the Skeleton.Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.Review article: effects of type 2 diabetes therapies on bone metabolism.The impact of type 2 diabetes on bone metabolism.Weak bones in diabetes mellitus - an update on pharmaceutical treatment options.Untangling the Causality Knot: Another Tool for Clinical Researchers
P2860
Q33691585-5DAC36B3-1B89-459E-A06B-ACF1A61454B1Q35964678-79A42C4F-C8BA-4B4E-84BC-B2213FBA782FQ36410243-A84D915B-3420-4903-A23A-4B28B71928B3Q37582364-12C3FCC6-37F4-46D7-AD2C-D8471D91FBCFQ38999214-AE05FDA1-9BDC-4B7B-9715-EE2A527D0C41Q39410329-3BCDD028-1CDC-4A50-B60A-C81EB6DA88E9Q42363966-CAE3EFC7-09CD-4F88-99D0-C676AC6EB69CQ42660007-780592C1-377B-45B0-A0C2-16ED9AB51EA3Q47855337-DDE26066-1F8F-4F3A-9728-FA9B8CEAA425Q57711320-3A39C945-318E-4DDD-9DB0-9F0563CFD1C5
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Safety of Anti-Diabetic Therapies on Bone.
@ast
Safety of Anti-Diabetic Therapies on Bone.
@en
type
label
Safety of Anti-Diabetic Therapies on Bone.
@ast
Safety of Anti-Diabetic Therapies on Bone.
@en
prefLabel
Safety of Anti-Diabetic Therapies on Bone.
@ast
Safety of Anti-Diabetic Therapies on Bone.
@en
P2860
P1476
Safety of Anti-Diabetic Therapies on Bone.
@en
P2093
Beata Lecka-Czernik
P2860
P2888
P356
10.1007/S12018-012-9129-7
P577
2012-02-07T00:00:00Z